370 likes | 928 Views
2. How cellular oncogenes arise. 3. Cellular oncogenes arise from proto-oncogenes. Proto-oncogenes are not bad genesNormal genes for regulation of cell proliferation and survivalWhen it change the structure and activity by mutation: causing cancerGain-of-function mutation. 4. Cellular oncogenes were initially detected in gene transfer experiments.
E N D
1. 1
2. 2 How cellular oncogenes arise
3. 3 Cellular oncogenes arise from proto-oncogenes Proto-oncogenes are not bad genes
Normal genes for regulation of cell proliferation and survival
When it change the structure and activity by mutation: causing cancer
Gain-of-function mutation
4. 4 Cellular oncogenes were initially detected in gene transfer experiments Gene transfer test: Isolate tumor cells DNA ? introduce into normal cells ? transformation test
In 1980S, human bladder cancers DNA ? mouse cells ? cancer
Gene cloning techniques: gene size fragment of DNA
First human cellular oncogene: RAS oncogen
Cellular oncogene and viral oncogene
RAS oncogene and v-ras
Cellular oncogene arise mechanism: point mutation (2) gene amplification (3) chromosomal translocation (4) DNA rearrangement (5) insertional mutagenesis
5. 5 Mechanism 1: point mutation can convert proto-oncogenes into oncogenes Difference of normal RAS gene (proto-oncogene) and abnormal RAS gene (an oncogene): a single nucleotide base (F. 9-1)
RAS oncogene point mutation is detected in cancer of bladder, lung, colon, pancrease, and thyroid
Mutation of RAS gene by carcinogens: asbestos, vinyl chloride, dimethylbenzanthracene
RET gene ? RET oncogene (by point mutation) ? abnormal Ret receptor protein
6. 6
7. 7 Mechanism 2: gene amplification can convert proto-oncogenes into oncogenes Replicating of DNA in specific chromosome region
F. 9-2
The main types examined by light microscopy: homogeneously staining regions (HSRs) and double minutes (DMs)
Amplified DNA containing from several dozen to several hundred copies of one or more genes
Most amplified genes are actively expressed
Produce normal but excessive protein
MYC gene family: MYC, MYCL, MYCN
By gene amplification for human cancer
F. 9-3
8. 8 ERBB2 gene amplification involved in 25% of all breast and ovarian cancers
MYCN gene amplication: neuroblastoma
9. 9
10. 10
11. 11 Mechanism 3: chromosomal translocation can convert proto-oncogene into oncogene Philadelphia chromosome: chromosome 22 abnormal
Associated with 90% chronic myelogeneous leukemia (CML)
Chromosome 9 and 22 reciprocal chromosome exchange
ABL and BCR gene (F. 9-4): BCR-ABL fusion gene (in chromosome 22)
fusion protein production
12. 12 Chromosome 8 and 14 translocation: Burkitts lymphoma
MYC proto-oncogene translocation
Overexpression of normal Myc protein
Chromosome 3-5, 6-9, 7-11, 8-16, 9-12, 12-22, 16-21 translocation for cancer development
13. 13
14. 14 Mechanism 4: local DNA rearrangements can convert proto-oncogenes into oncogenes F. 9-5
DNA deletions, insertions, transpositions, and inversions
TRK oncogene: fusion gene
Trk fusion protein
(F. 9-6)
15. 15
16. 16
17. 17 Mechanism 5: insertional mutagenesis can convert proto-oncogenes into oncogenes Cancer virus gene insertion
18. 18 Summing up: cellular oncogenes arise from proto-oncogenes by mechanisms that alter gene structure or expression F. 9-7
19. 19
20. 20 Proteins produced by oncogenes Table 9-1
Most of the proteins produced by oncogene are components of signaling pathways that promote cell proliferation and survival
21. 21
22. 22
23. 23 Oncogenes typically code for components of signaling pathways that activate cell proliferation Example: Ras-MAPK pathway (F. 9-8)
One of several signaling mechanisms
24. 24
25. 25 Some oncogenes produce growth factors v-sis oncogene (from simian sarcoma virus)
Mutant form PDGF
26. 26 Some oncogenes produce receptor proteins F. 9-9
v-erb-b oncogene: constitutively active EFG receptor (F. 9-9b)
ERBB2 gene: overexpression of receptor (F. 9-9c)
Jak-STAT pathway (F. 9-10)
STAT ( Signal Transduction and Activators of Transcript): a cytoplasmic protein
v-mpl oncogene code for a mutant receptor for thrombopoietin
Trigger a Jak-STAT pathway
27. 27
28. 28
29. 29 Some oncogenes produce plasma membrane G protein F. 9-11
RAS proto-oncogene: HRAS, KRAS, and NRAS
Point mutation: abnormal Ras protein production
Hyperactive Ras protein (binding with GTP)
~30% of all human cancer
KRAS is the most frequently mutated in human cancers
30. 30
31. 31 Some oncogenes produce intracellular protein kinases Intracellular serine/threonine kinases
BRAF oncogene: mutant form Raf kinase
2/3 melanomas
Tyrosine kinase are also involved in intracellular signaling pathways (nonreceptor tyrosine kinase)
Three examples of nonreceptor tyrosine kinases
Src kinase: phosphorylated receptor
Jak kinase:
Chromosome 9 and 12: TEL-JAK2 fused gene
Tyrosine kinase activity in Jak kinase
Abl kinase
ABL proto-oncogene
BCR-ABL oncogene for abnormal version of the Abl tyrosine kinase
Cannot trigger apoptosis
32. 32 Some oncogenes produce transcription factors Myc protein
avian leukosis virus (retro virus)
Enhance normal Myc protein expression
avian myelocytomatosis virus
v-myc oncogene
Abnormal Myc protein
Epstein-Barr virus
MYC gene translocation (to chromosome 14)
Burkitts lymphoma
Myc is just one of several transcription factors that produced by oncogenes
v-fos, v-jun, v-myb, v-ets, and v-erb-a
33. 33 Some oncogenes produce cell cycle or cell death regulators For Cdks and cyclins
CDK4 gene
CYCD1 gene for cyclin
BCL2 gene: Bcl2 protein
34. 34 Summing up: oncogene-induced disruptions in signaling pathways exhibit some common themes